What's Happening?
Three faculty members from the Technion-Israel Institute of Technology have been awarded research grants by the Israel Cancer Research Fund. These grants aim to support innovative research into cancer and its interaction with other health conditions.
Professor Irit Ben Aharon is investigating the effects of chemotherapy on children born to mothers who underwent cancer treatment during pregnancy. Dr. Ido Livneh is exploring the 'backup systems' that allow cancer cells to survive treatment. Dr. Shira Landau is developing an Organ-on-a-Chip model to study the interaction between cancer and heart disease. These studies are part of a broader effort to understand and manage cancer as a chronic disease.
Why It's Important?
The research funded by these grants could significantly impact cancer treatment and management. By understanding how cancer cells survive treatment, new strategies could be developed to prevent recurrence. The study of chemotherapy's effects on children born to treated mothers could lead to better guidelines for managing cancer during pregnancy. Additionally, the Organ-on-a-Chip model could provide insights into the biological communication between cancer and heart disease, potentially leading to new therapeutic approaches. These advancements could improve patient outcomes and quality of life, particularly for those with complex health conditions.
